Concussion-detecting headset maker eyes US market
Headsafe's Nurochek concussion-screening headset has won US FDA approval, with development earlier backed by a $447,500 AMGC grant; the company is now pursuing certifications in several more regions.
Company · Healthcare · AI
Every investor coverage indicates participated in a round Headsafe raised.
Investors whose own portfolio pages list Headsafe, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Artesian VC | its portfolio page ↗ |
| Artesian VC | its portfolio page ↗ |
| Investible | its portfolio page ↗ |
Companies Headsafe acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Adrian Cohen | Founder & Chief Innovation Officer | @AuManufacturing, Headsafe team page |
Stories naming Headsafe. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Headsafe's Nurochek concussion-screening headset has won US FDA approval, with development earlier backed by a $447,500 AMGC grant; the company is now pursuing certifications in several more regions.
Fifteen Australian manufacturers share $7.16 million in federal Commercialisation Fund grants across two tranches, with industry contributing $17.95 million toward projects spanning clean energy, medical devices, recycling, defence and food technology.